# Submission Documentation for Sterilization Process Validation in Applications for Human and Veterinary Drug Products:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/submission-documentation-for-sterilization-process-validation-in-applications-for-human-and-veterinary-drug-products-guidance-for-industry/de753251-391e-49ff-a5ac-26a5cad0728a

> FDA guidance document: Submission Documentation for Sterilization Process Validation in Applications for Human and Veterinary Drug Products:  Guidance for Industry. Issue date: November 01, 1994. Get complete insights and analysis.

---

## Details

- Title: Submission Documentation for Sterilization Process Validation in Applications for Human and Veterinary Drug Products:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: veterinary
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1994-11-01
- Last Changed: 2020-05-05

## Related Documents

- [Guidance for Industry for the Submission of Chemistry, Manufacturing, and Controls Information for a Therapeutic Recombinant DNA-Derived Product or a Monoclonal Antibody Product for In Vivo Use](https://www.globalkeysolutions.net/guidances/guidance-document/guidance-for-industry-for-the-submission-of-chemistry-manufacturing-and-controls-information-for-a-therapeutic-recombinant-dna-derived-product-or-a-monoclonal-antibody-product-for-in-vivo-use/1c78a87a-d482-4f5d-9d0e-b273649f563f)
- [Q5B Quality of Biotechnological Products: Analysis of the Expression Construct in Cells Used for Production of r-DNA Derived Protein Products](https://www.globalkeysolutions.net/guidances/guidance-document/q5b-quality-of-biotechnological-products-analysis-of-the-expression-construct-in-cells-used-for-production-of-r-dna-derived-protein-products/245613c2-f488-4d8f-a017-e16fbd69e2ed)
- [Content and Format of Investigational New Drug Applications (INDs) for Phase 1 Studies of Drugs, Including Well-Characterized, Therapeutic, Biotechnology-derived Products:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/content-and-format-of-investigational-new-drug-applications-inds-for-phase-1-studies-of-drugs-including-well-characterized-therapeutic-biotechnology-derived-products-guidance-for-industry/ecc5878c-4062-49df-90cc-6ac91b3adb4c)